Mohammed Alshaikheid

Years Active: 2019-2021
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Helmi Ammar, Zohra Chadli, Ahmed Mhalla, Sabria Khouadja, Ibtissem Hannachi, Mohammed Alshaikheid, Ahlem Slama, Nadia Ben Fredj, Najeh Ben Fadhel, Haifa Ben Romdhane, Amel Chaabane, Naceur A Boughattas, Lotfi Gaha, Lazhar Zarrouk, Karim Aouam
Clinical and genetic influencing factors on clozapine pharmacokinetics in Tunisian schizophrenic patients. The pharmacogenomics journal 21 (5) (2021)
Mohammed Alshaikheid, Nadia Ben Fredj, Ibtissem Hannachi, Naourez Kolsi, Najah Ben Fadhel, Emna Kerkeni, Haifa Ben Romdhane, Amel Chaabane, Jamel Koubaa, Zohra Chadli, Karim Aouam
Development of a population pharmacokinetic model and Bayesian estimators for isoniazid in Tunisian tuberculosis patients. The pharmacogenomics journal 21 (4) (2021)
Mohammed Alshaikheid, Haifa Ben Romdhane, Nadia Ben Fredj, Najah Ben Fadhel, Abir Aouam, Zohra Chadli, Naceur Boughattas, Amel Chaabane, Karim Aouam
Isoniazid Therapeutic Drug Monitoring in Tunisian Patients With Tuberculosis. Journal of clinical pharmacology 61 (7) (2021)
Mohammed Alshaikheid, Amel Chaabane, Nadia Ben Fredj, Hajer Ben Brahim, Najah Ben Fadhel, Zohra Chadli, Ahlem Slama, Naceur A Boughattas, Mohamed Chakroun, Karim Aouam
Limited sampling strategy for predicting isoniazid exposure in patients with extrapulmonary tuberculosis. Journal of clinical pharmacy and therapeutics 45 (3) (2019)

Mohammed Alshaikheid.css-eqlu8i{font-size:small;padding-left:4px;}